Article
Phosphodiesterase sequence variants may predispose to prostate cancer.
Endocrine-related cancer - 1 Aug 2015
de Alexandre Rodrigo B, Horvath Anelia D, Szarek Eva, Manning Allison D, Leal Leticia F, Kardauke Fabio, Epstein Jonathan A, Carraro Dirce M, Soares Fernando A, Apanasovich Tatiyana V, Stratakis Constantine A, Faucz Fabio R
Abstract excerpt
We hypothesized that mutations that inactivate phosphodiesterase (PDE) activity and lead to increased cAMP and cyclic guanosine monophosphate levels may be associated with prostate cancer (PCa). We sequenced the entire PDE coding sequences in the DNA of 16 biopsy samples from PCa patients. Novel mutations were confirmed in the somatic or germline state by Sanger sequencing. Data were then compared to the 1000...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
